ESRD (End-Stage Renal Disease)
Nephrology·MeSH: Renal Insufficiency, Chronic
Prevalence
230.0 / 100K
Incidence
40.0 / 100K/yr
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for ESRD (End-Stage Renal Disease)?
BioSniper tracks 2 drugs in development for ESRD (End-Stage Renal Disease) across 1 company.
How many clinical trials target ESRD (End-Stage Renal Disease)?
There are 3 clinical trials targeting ESRD (End-Stage Renal Disease) tracked by BioSniper.
What is the prevalence of ESRD (End-Stage Renal Disease)?
The estimated prevalence of ESRD (End-Stage Renal Disease) is approximately 230.0 per 100,000 population.
Deep-dive into ESRD (End-Stage Renal Disease)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis